Pulmonx (LUNG) Non-Current Deferred Tax Liability (2019 - 2025)

Pulmonx (LUNG) has 7 years of Non-Current Deferred Tax Liability data on file, last reported at $69000.0 in Q4 2025.

• On a quarterly basis, Non-Current Deferred Tax Liability fell 20.69% year-over-year to $69000.0 in Q4 2025; TTM through Dec 2025 was $69000.0, a 20.69% decrease from a year earlier, with the FY2025 full-year figure at $69000.0, down 20.69% from the prior year.
• Non-Current Deferred Tax Liability for Q4 2025 stood at $69000.0, up from $47000.0 in the prior quarter.
• Over the last five years, Non-Current Deferred Tax Liability for LUNG reached as high as $1.3 million in Q4 2023 and fell as low as $37000.0 in Q4 2021.
• Historically, Non-Current Deferred Tax Liability has averaged $137500.0 across 5 years, with a median of $71000.0 in 2021.
• Across the five-year window, Non-Current Deferred Tax Liability soared 1265.96% in 2023 and tumbled 93.22% in 2024, its largest moves.
• Year by year, Non-Current Deferred Tax Liability stood at $37000.0 in 2021, then jumped by 154.05% to $94000.0 in 2022, then surged by 1265.96% to $1.3 million in 2023, then tumbled by 93.22% to $87000.0 in 2024, then retreated by 20.69% to $69000.0 in 2025.
• Per Business Quant data, the three most recent Non-Current Deferred Tax Liability figures were $69000.0 in Q4 2025, $47000.0 in Q3 2025, and $41000.0 in Q2 2025.